Top Qs
Timeline
Chat
Perspective
Olpasiran
From Wikipedia, the free encyclopedia
Remove ads
[1]Olpasiran (AMG890) is an experimental siRNA (short interfering RNA) therapy designed to lower the level of lipoprotein(a), which is believed to be a causal factor in the development of cardiovascular disease. The drug is developed by Amgen.[2][3]
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads